Daniel K. Spiegelman

Daniel K. Spiegelman

DirectoratKyverna Therapeutics· In proxies 2024–2025

Daniel K. Spiegelman sits on 6 public boards.

Boards1

  • Kyverna TherapeuticsDirector · 3 yr on the boardIndependentAudit (Chair)—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Kyverna TherapeuticsPublic company · 2 yr
    • Director2024 – Present · 2 yrStock in role -80%
  2. Maze Therapeutics Inc.Public company
    • Director? – PresentNo stock prices for these years
  3. Spruce Biosciences, Inc.Public company
    • Director? – PresentNo stock prices for these years
  4. Tizona Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  5. vTv Therapeutics Inc.Public company
    • Director? – PresentNo stock prices for these years
  6. Myriad Genetics, Inc.Public company · 4 yr
    • Director2020 – 2024 · 4 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?